Novartis Pharma AG
Novartis Pharma AG, commonly referred to as Novartis, is a leading global healthcare company headquartered in Switzerland (CH). Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in innovative pharmaceuticals and generics, Novartis focuses on areas such as oncology, cardiology, immunology, and neuroscience. The company is renowned for its commitment to research and development, producing unique therapies that address unmet medical needs. With a robust portfolio of patented medications and a significant market position, Novartis has achieved numerous accolades, including recognition for its contributions to advancing healthcare and improving patient outcomes worldwide.
DitchCarbon Score
How does Novartis Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novartis Pharma AG's score of 68 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novartis Pharma AG's reported carbon emissions
Novartis Pharma AG, headquartered in Switzerland (CH), currently does not provide specific carbon emissions data or reduction targets. Without available emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely engaged in various climate commitments and initiatives typical of the pharmaceutical industry, focusing on sustainability and reducing environmental impact. As the industry increasingly prioritises climate action, Novartis may be working towards establishing measurable targets and strategies to enhance their environmental performance in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novartis Pharma AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
